Polycystic Ovarian Syndrome
Conditions
Brief summary
To evaluate possible clinical effects of adipokines , ( ghrelin, resistin and adiponectin), in obese and non-obese patients with polycystic ovary syndrome (PCOS).
Detailed description
Seventy selected PCOS patients will be recruited for this study, and will be divided into two groups based on their body mass index (BMI): 35 obese (BMI≥ 25 kg/m2, group A), 35 non-obese (BMI\<25 kg/m2, group B). In addition, 35 healthy non-obese women (BMI\<25 kg/m2) will bw enrolled as the control (group C). Serum levels of FSH (follicle stimulating hormone), LH (luteinizing hormone), T(testosterone), glucose, insulin, adiponectin, resistin and resistin will bw detected, and compared the differences of them among three groups
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Females with PCOS in child bearing age who presented at reproductive and endocrinology clinics at Ain Shams University Maternity Hospital
Exclusion criteria
* Known androgen secreting tumor. * PCO on ovarian stimulation medications * PCO with any other medical illness.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| serum ghrelin level | 24 hours | measuring ghrelin, and ) in the three groups |
| serum resistin level | 24 hours | serum resistin level in the three groups |
| serum adiponectin level | 24 hours | serum adiponectin level in the three groups |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Glucose/Insulin ratio | 24 hours | fasting glucose and insulin in three groups |
| serum testosterone level | 24 hours after labor | serum testosterone level in three groups |
Countries
Egypt